Physician profile
Ajith Thomas
NPI 1972525541
$3,107.09
in general payments reported to CMS, 2019-2025
12 companies · $307 in 2025
The $307 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $695 · 2020: $20.89 · 2021: $11.80 · 2022: $184 · 2023: $1,580 · 2024: $309 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,350 · Food and Beverage: $845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,350.00 |
| Food and Beverage | $845.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $1,350.00 | 2023 | |
| Stryker Corporation | $672.73 | 2019 | |
| Rapid Medical Ltd | $340.85 | 2023-2024 | Tigertriever 17 Revascularization Device, Comaneci 17 |
| Imperative Care, INC | $191.44 | 2024-2025 | Zoom 88-T Large Distal Platform |
| Route 92 Medical, INC. | $165.06 | 2022 | |
| Medtronic, INC. | $130.19 | 2025 | Percept Pc Brainsense |
| Icotec Medical INC. | $79.80 | 2023 | Vader Pedicle System |
| Depuy Synthes Sales INC. | $51.26 | 2025 | Trufill |
| Medtronic USA, INC. | $43.40 | 2019-2020 | |
| Chiesi USA, INC. | $36.26 | 2021-2025 | Cleviprex |
| Genentech USA, INC. | $27.44 | 2025 | Ocrevus Zunovo |
| Astrazeneca Pharmaceuticals Lp | $18.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajith Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.